Skip to main content
TG THERAPEUTICS, INC. logo

TG THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · TGTX ISIN · US88322Q1085 LEI · 529900X21UKABN9NJ529 US Manufacturing
Open in API
Filings indexed 1,012 across all filing types
Latest filing 2020-06-25 Director's Dealing
Country US United States of America
Listing US TGTX

About TG THERAPEUTICS, INC.

https://www.tgtherapeutics.com/

TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. The company's primary area of focus is autoimmune diseases, particularly multiple sclerosis (MS). Its lead commercial product is BRIUMVI® (ublituximab), an approved therapy for adults with relapsing forms of MS. TG Therapeutics also develops a pipeline of potential therapies for B-cell malignancies and other autoimmune conditions, including investigational CAR-T cell therapies.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2020-06-25 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about the 2020 Annual Meeting of TG Therapeutics, Inc., including voting results on various proposals such as the election of directors, ratification of auditors, and approval of an amendment to the stock incentive plan. It also includes an item about the departure and election of directors and officers. The document does not contain full financial statements or detailed financial analysis but rather reports on governance and shareholder voting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 6895 characters, which is sufficient for a detailed voting result report. Therefore, the appropriate classification is DVA with high confidence.
2020-06-24 English
SC 13G/A
Major Shareholding Notification
2020-06-10 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-06-10 English
PX14A6G
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a PX14A6G filing, which is a type of proxy solicitation communication. It contains a letter from CalPERS urging shareholders to support a shareholder proposal (#4) regarding majority voting for director elections at the upcoming Annual General Meeting. The content is focused on soliciting votes and providing information related to a shareholder proposal, not the actual proxy statement or meeting materials themselves. The document is relatively short (3353 characters) and is a solicitation letter rather than a full proxy statement or voting results. Therefore, it fits best under Proxy Solicitation & Information Statement (PSI).
2020-05-29 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically an underwriting agreement for a public offering of common stock. It details the terms of the offering, the parties involved, and related legal opinions. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is not a proxy, voting result, or management change announcement. It is clearly an update on a capital raising transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (7735 characters) supports that this is a substantive filing, not just a brief announcement or certification. Confidence is high given the clear description of the underwriting agreement and offering details.
2020-05-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.